potassium citrate anhydrous
1,2,3-propanetricarboxylic acid, 2-hydroxy-, potassium salt (1:3)
Identification
| Name | potassium citrate anhydrous |
| IUPAC | tripotassium 2-hydroxypropane-1,2,3-tricarboxylate |
| CAS Number | 866-84-2 |
| EINECS | 212-755-5 |
| FDA UNII | 86R1NVR0HW |
| Molecular Formula | C6 H5 K3 O7 |
| Molecular Weight | 306.39515000 |
| MDL Number | MFCD00150442 |
| Nikkaji Number | J7.148J |
Regulatory
| FDA/DG SANTE Petitions, Reviews, Notices | 184.1625 |
| JECFA Food Additive | Potassium Dihydrogen Citrate |
| GSFA Codex | Potassium dihydrogen citrate (332(i)) |
| FDA Mainterm (IAUFC) | 866-84-2 ; TRIPOTASSIUM CITRATE |
Physical Properties
| Appearance | white crystalline powder (est) |
| Assay | 99.00 to 100.00 |
| Food Chemicals Codex Listed | No |
| logP (o/w) | -0.280 (est) |
| Soluble in | water, 606000 mg/L @ 25 °C (exp) |
Cosmetic Information
| CosIng | cosmetic data |
| Cosmetic Uses | buffering agents |
Organoleptic Properties
| Odor Description | at 100.00 %. |
Safety Information
| Oral/Parenteral Toxicity | Not determined |
| Dermal Toxicity | Not determined |
| Inhalation Toxicity | Not determined |
GHS Classification
['GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)', 'GHS Label elements, including precautionary statements']
Safety in Use
| Category | buffering agents, sequestrants, yeast food |
| Recommendation for potassium citrate anhydrous usage levels up to | not for fragrance use. |
| Recommendation for potassium citrate anhydrous flavor usage levels up to | not for flavor use. |
No supplier data available
Potential Uses
Natural Occurrence
Synonyms
citric acid, potassium salt
potassium tribasic citrate
1,2,3-
propanetricarboxylic acid, 2-hydroxy-, potassium salt
1,2,3-
propanetricarboxylic acid, 2-hydroxy-, potassium salt (1:3)
1,2,3-
propanetricarboxylic acid, 2-hydroxy-, tripotassium salt
tripotassium 2-hydroxypropane-1,2,3-tricarboxylate
tripotassium cirtate
tripotassium citrate
tripotassium citrate anhydrous
PubMed:
Reappraisal of the quantity and nature of renal calcifications and mineral metabolism in the magnesium-deficient rat. Effects of treatment with potassium citrate or the combination magnesium citrate and potassium citrate.
PubMed:
Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis.
PubMed:
New drug therapy for kidney stones: a review of cellulose sodium phosphate, acetohydroxamic acid, and potassium citrate.